Feb 19, 2026 First Group Leaders announced for new dedicated Parkinson's Research Centre In 2025, the UK DRI partnered with Parkinson’s UK to launch a new £10m research... Learn more First Group Leaders announced for new dedicated Parkinson's Research Centre
Jan 01, 2024 Why partner with the UK DRI? The UK DRI is central to a rich and connected dementia research ecosystem, and we... Learn more Why partner with the UK DRI?
Jan 01, 2024 Why join the UK DRI? By joining the UK DRI you’ll belong to a team of world-class researchers, technical specialists... Learn more Why join the UK DRI?
Search for keywords Condition ConditionAlzheimer's diseaseFrontotemporal dementiaHuntington's diseaseLewy body dementiaMild cognitive impairmentMotor neuron disease/ALSOther conditionsParkinson's diseaseVascular dementia Techniques TechniquesAdvanced microscopy & imagingAdvanced spectroscopyBioinformaticsBiophysical techniquesCRISPRDrug screeningElectrophysiologyEpigenomicsExperimental medicineFlow cytometryFluid biomarkersGenomicsHuman brain imagingLipidomicsMass spec-based proteomicsMetabolomicsMouse behaviourMouse in vivo imagingNext generation sequencingNon-mammalian animal modelsOptogeneticsRobotics & environmental sensingSingle cell / nucleus transcriptomicsSoftware developmentSpatial transcriptomicsStatistical modellingStem cells / iPSCsStructural biologyTranscranial brain stimulationViral-mediated expression Research Division Research Division Mei Miyazaki Kirby PhD Student Learn more Mei Miyazaki Kirby Dr Sarah Mizielinska Group Leader UK DRI at King's Understanding the precise mechanisms of nucleocytoplasmic dysfunction in FTD and ALS Learn more Dr Sarah Mizielinska Dr Amin Mohamed Abu Baker PhD Student Learn more Dr Amin Mohamed Abu Baker Mehreen Mohammad Research Assistant & Colony Manager Learn more Mehreen Mohammad Ms. Rahema Mohammad PhD student Learn more Ms. Rahema Mohammad Dr Axel Montagne Group Leader UK DRI at Edinburgh Exploring the link between cerebrovascular and inflamm-ageing to neurodegeneration and dementia Learn more Dr Axel Montagne Kylie-Ann Montgomery PhD Student Learn more Kylie-Ann Montgomery Dr Jimena Monzon Sandoval Bioinformatician Aiming to better understand molecular mechanisms driving altered gene expression and pathway dysregulation through transcriptomic analyses in disease models, aiding the identification of therapeutic targets for neurodegenerative diseases. Learn more Dr Jimena Monzon Sandoval Jay Moore PhD Student Mapping cell-type-specific vulnerability by integrating large-scale genomic and neuropathological data. Learn more Jay Moore Amelia Moore Research Assistant Learn more Amelia Moore Dr Pierre Mora Postdoctoral Researcher Learn more Dr Pierre Mora Dr Laura Morcom Postdoctoral Researcher Learn more Dr Laura Morcom Pagination First page First Previous page ‹ … Page 61 Page 62 Current page 63 Page 64 Page 65 … Next page › Last page Last
Dr Sarah Mizielinska Group Leader UK DRI at King's Understanding the precise mechanisms of nucleocytoplasmic dysfunction in FTD and ALS Learn more Dr Sarah Mizielinska
Dr Axel Montagne Group Leader UK DRI at Edinburgh Exploring the link between cerebrovascular and inflamm-ageing to neurodegeneration and dementia Learn more Dr Axel Montagne
Dr Jimena Monzon Sandoval Bioinformatician Aiming to better understand molecular mechanisms driving altered gene expression and pathway dysregulation through transcriptomic analyses in disease models, aiding the identification of therapeutic targets for neurodegenerative diseases. Learn more Dr Jimena Monzon Sandoval
Jay Moore PhD Student Mapping cell-type-specific vulnerability by integrating large-scale genomic and neuropathological data. Learn more Jay Moore
